Cargando…

Dose Modification of Antidiabetic Agents in Patients with Type 2 Diabetes Mellitus and Heart Failure

Heart failure is the most common comorbidity of diabetes. The incidence of heart failure in patients with diabetes is about 9%–22%, which is four times higher Than that in patients without diabetes. Heart failure and diabetes are collectively associated with increased morbidity and mortality compare...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sharma, D. C., Asirvatham, Arthur, Singh, Parminder
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Medknow Publications & Media Pvt Ltd 2017
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5477452/ https://www.ncbi.nlm.nih.gov/pubmed/28670548 http://dx.doi.org/10.4103/ijem.IJEM_442_16

Ejemplares similares

Consensus Statement on Dose Modifications of Antidiabetic Agents in Patients with Hepatic Impairment
por: Gangopadhyay, Kalyan Kumar, et al.
Publicado: (2017)

The effects of antidiabetic agents on heart failure
por: Wijnen, M., et al.
Publicado: (2021)

Insulin treatment in patients with diabetes mellitus and heart failure in the era of new antidiabetic medications
por: Staszewsky, Lidia, et al.
Publicado: (2022)

Insulin versus an oral antidiabetic agent as add-on therapy in type 2 diabetes after failure of an oral antidiabetic regimen: a meta-analysis
por: Gamble, JM, et al.
Publicado: (2008)

Clinical Review of Antidiabetic Drugs: Implications for Type 2 Diabetes Mellitus Management
por: Chaudhury, Arun, et al.
Publicado: (2017)

Glinus lotoides linn. Seed extract as antidiabetic agent: In vitro and in vivo anti-glucolipotoxicity efficacy in Type-II diabetes mellitus
por: Sisay, Woretaw, et al.
Publicado: (2022)

Efficacy of Various Antidiabetic Agents as Add-On Treatments to Metformin in Type 2 Diabetes Mellitus: Systematic Review and Meta-Analysis
por: Poolsup, Nalinee, et al.
Publicado: (2012)

Clinical outcomes of basal insulin and oral antidiabetic agents as an add-on to dual therapy in patients with type 2 diabetes mellitus
por: Cheng, Chih-Ning, et al.
Publicado: (2020)

Persistence of initial oral antidiabetic treatment in patients with type 2 diabetes mellitus
por: Jermendy, György, et al.
Publicado: (2012)

Heart Failure With Type 2 Diabetes Mellitus: Association Between Antihyperglycemic Agents, Glycemic Control, and Ejection Fraction
por: Lin, Shu Ning, et al.
Publicado: (2020)

The Impact of Antidiabetic Agents on Sarcopenia in Type 2 Diabetes: A Literature Review
por: Wu, Chen-Ning, et al.
Publicado: (2020)

Role of antidiabetic agents in type 2 diabetes patients with chronic kidney disease
por: Lin, Wei-Ren, et al.
Publicado: (2023)

Diabetes mellitus-related hospital admissions and prescriptions of antidiabetic agents in England and Wales: an ecological study
por: AbuHammad, Gayda Abdel Rahman, et al.
Publicado: (2023)

Diabetes Mellitus and Heart Failure
por: Triposkiadis, Filippos, et al.
Publicado: (2021)

Diabetes Mellitus and Heart Failure
por: Siao, Wun-Zhih, et al.
Publicado: (2022)

Glycemic control and antidiabetic drugs in type 2 diabetes mellitus patients with renal complications
por: Huri, Hasniza Zaman, et al.
Publicado: (2015)

Noninsulin Antidiabetic Drugs for Patients with Type 2 Diabetes Mellitus: Are We Respecting Their Contraindications?
por: Ruiz-Tamayo, Irene, et al.
Publicado: (2016)

Gut Microbiota and Antidiabetic Drugs: Perspectives of Personalized Treatment in Type 2 Diabetes Mellitus
por: Liu, Wenhui, et al.
Publicado: (2022)

Depression is associated with heart failure in patients with type 2 diabetes mellitus
por: Chen, Yanying, et al.
Publicado: (2023)

Alterations of Gut Microbiota in Type 2 Diabetes Individuals and the Confounding Effect of Antidiabetic Agents
por: Almugadam, Babiker Saad, et al.
Publicado: (2020)

Evaluating the antidiabetic effects of R-verapamil in type 1 and type 2 diabetes mellitus mouse models
por: Chen, Yu-Syuan, et al.
Publicado: (2021)

Relationship Between Body Mass Index, Antidiabetic Agents, and Midterm Mortality in Patients With Both Type 2 Diabetes Mellitus and Acute Coronary Syndrome
por: Jong, Chien‐Boon, et al.
Publicado: (2019)

De-Intensification of Antidiabetic Treatment Using Canagliflozin in Patients with Heart Failure and Type 2 Diabetes: Cana-Switch-HF Study
por: Pérez-Belmonte, Luis M., et al.
Publicado: (2021)

Antidiabetic Effects of Gastric Banding Surgery in Morbidly Obese Patients with Type 2 Diabetes Mellitus
por: Kim, Yu-Jeng, et al.
Publicado: (2017)

Evaluation of statin prescriptions in type 2 diabetes: India Heart Watch-2
por: Gupta, Rajeev, et al.
Publicado: (2016)

Association of depression with evolution of heart failure in patients with type 2 diabetes mellitus
por: Wang, Ying, et al.
Publicado: (2018)

Complexity of antidiabetic medication regimen is associated with increased diabetes-related distress in persons with type 2 diabetes mellitus
por: Luzuriaga, Maria, et al.
Publicado: (2021)

Tissue Factor Expression in Obese Type 2 Diabetic Subjects and Its Regulation by Antidiabetic Agents
por: Wang, Jing, et al.
Publicado: (2015)

Geographic Variation in Antidiabetic Agent Adherence and Glycemic Control Among Patients with Type 2 Diabetes
por: Tan, Eleonora, et al.
Publicado: (2015)

Insulin Fact Sheet in Type 1 and 2 Diabetes Mellitus and Trends of Antidiabetic Medication Use in Insulin Users with Type 2 Diabetes Mellitus: 2002 to 2019
por: Park, Jiyun, et al.
Publicado: (2023)

Antidiabetic Effect of Brain-Derived Neurotrophic Factor and Its Association with Inflammation in Type 2 Diabetes Mellitus
por: Eyileten, Ceren, et al.
Publicado: (2017)

Hypoglycaemia and accident risk in people with type 2 diabetes mellitus treated with non-insulin antidiabetes drugs
por: Signorovitch, J E, et al.
Publicado: (2013)

Association between glycemic control and antidiabetic drugs in type 2 diabetes mellitus patients with cardiovascular complications
por: Huri, Hasniza Zaman, et al.
Publicado: (2015)

The Mechanism of Metabolic Influences on the Endogenous GLP-1 by Oral Antidiabetic Medications in Type 2 Diabetes Mellitus
por: Nguyen, Thiquynhnga, et al.
Publicado: (2020)

Comparison of the Effects of Various Antidiabetic Medication on Bone Mineral Density in Patients with Type 2 Diabetes Mellitus
por: Ha, Jeonghoon, et al.
Publicado: (2021)

The Effects of Cardioprotective Antidiabetic Therapy on Microbiota in Patients with Type 2 Diabetes Mellitus—A Systematic Review
por: Bica, Ioana-Cristina, et al.
Publicado: (2023)

Insulin Glargine Combined with Oral Antidiabetic Drugs for Asians with Type 2 Diabetes Mellitus: A Pooled Analysis to Identify Predictors of Dose and Treatment Response
por: Gu, Tianwei, et al.
Publicado: (2018)

Mechanisms of Antidiabetic Activity of Methanolic Extract of Punica granatum Leaves in Nicotinamide/Streptozotocin-Induced Type 2 Diabetes in Rats
por: Pottathil, Shinu, et al.
Publicado: (2020)

Heart Failure and Diabetes Mellitus: Dangerous Liaisons
por: Lee, Hae-Young
Publicado: (2022)

Canagliflozin and Heart Failure in Type 2 Diabetes Mellitus: Results From the CANVAS Program
por: Rådholm, Karin, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_rrepnpkpqlego3mu2kqbcc3na7